BACKGROUND: Orthotopic mouse models of human cancer represent an important in vivo tool for drug testing and validation. Most of the human thyroid carcinoma cell lines used in orthotopic or subcutaneous models are likely of melanoma and colon cancer. Here, we report and characterize a novel orthotopic model of human thyroid carcinoma using a unique thyroid cancer cell line. METHODS: We used the cell line 8505c, originated from a thyroid tumor histologically characterized by anaplastic carcinoma cell features. We injected 8505c cells engineered using a green fluorescent protein-positive lentiviral vector orthotopically into the thyroid of severe combined immunodeficient mice. RESULTS: Orthotopic implantation with the 8505c cells produced thyroid tumors after 5 weeks, showing large neck masses, with histopathologic features of a high-grade neoplasm (anaplasia, necrosis, high mitotic and proliferative indexes, p53 positivity, extrathyroidal invasion, lymph node and distant metastases) and immunoprofile of follicular thyroid cell origin with positivity for thyroid transcription factor-1 and PAX8, and for cytokeratins. CONCLUSIONS: Here we describe a novel orthotopic thyroid carcinoma model using 8505c cells. This model can prove to be a reliable and useful tool to investigate in vivo biological mechanisms determining thyroid cancer aggressiveness, and to test novel therapeutics for the treatment of refractory or advanced thyroid cancers.
BACKGROUND: Orthotopic mouse models of humancancer represent an important in vivo tool for drug testing and validation. Most of the humanthyroid carcinoma cell lines used in orthotopic or subcutaneous models are likely of melanoma and colon cancer. Here, we report and characterize a novel orthotopic model of humanthyroid carcinoma using a unique thyroid cancer cell line. METHODS: We used the cell line 8505c, originated from a thyroid tumor histologically characterized by anaplastic carcinoma cell features. We injected 8505c cells engineered using a green fluorescent protein-positive lentiviral vector orthotopically into the thyroid of severe combined immunodeficientmice. RESULTS: Orthotopic implantation with the 8505c cells produced thyroid tumors after 5 weeks, showing large neck masses, with histopathologic features of a high-grade neoplasm (anaplasia, necrosis, high mitotic and proliferative indexes, p53 positivity, extrathyroidal invasion, lymph node and distant metastases) and immunoprofile of follicular thyroid cell origin with positivity for thyroid transcription factor-1 and PAX8, and for cytokeratins. CONCLUSIONS: Here we describe a novel orthotopic thyroid carcinoma model using 8505c cells. This model can prove to be a reliable and useful tool to investigate in vivo biological mechanisms determining thyroid cancer aggressiveness, and to test novel therapeutics for the treatment of refractory or advanced thyroid cancers.
Authors: Volkert B Wreesmann; Ronald A Ghossein; Snehal G Patel; Charles P Harris; Erik A Schnaser; Ashok R Shaha; R Michael Tuttle; Jatin P Shah; Pulivarthi H Rao; Bhuvanesh Singh Journal: Am J Pathol Date: 2002-11 Impact factor: 4.307
Authors: R Kotchetkov; J Cinatl; A A Krivtchik; J U Vogel; J Matousek; P Pouckova; B Kornhuber; D Schwabe; J Cinatl Journal: Anticancer Res Date: 2001 Mar-Apr Impact factor: 2.480
Authors: Shahnaz Begum; Eli Rosenbaum; Rui Henrique; Yoram Cohen; David Sidransky; William H Westra Journal: Mod Pathol Date: 2004-11 Impact factor: 7.842
Authors: T H Kuo; T Kubota; M Watanabe; T Furukawa; S Kase; H Tanino; Y Saikawa; K Ishibiki; M Kitajima; R M Hoffman Journal: Anticancer Res Date: 1993 May-Jun Impact factor: 2.480
Authors: Pierre Vanden Borre; David G McFadden; Viswanath Gunda; Peter M Sadow; Shohreh Varmeh; Maria Bernasconi; Tyler Jacks; Sareh Parangi Journal: Thyroid Date: 2014-01-24 Impact factor: 6.568
Authors: Carrie C Lubitz; Tiannan Zhan; Viswanath Gunda; Salma Amin; Benjamin J Gigliotti; Abbey L Fingeret; Tammy M Holm; Heather Wachtel; Peter M Sadow; Lori J Wirth; Ryan J Sullivan; David J Panka; Sareh Parangi Journal: Thyroid Date: 2018-02-27 Impact factor: 6.568
Authors: Yanlan Liu; Viswanath Gunda; Xi Zhu; Xiaoding Xu; Jun Wu; Diana Askhatova; Omid C Farokhzad; Sareh Parangi; Jinjun Shi Journal: Proc Natl Acad Sci U S A Date: 2016-06-24 Impact factor: 11.205
Authors: Viswanath Gunda; Alexandria P Cogdill; Maria J Bernasconi; Jennifer A Wargo; Sareh Parangi Journal: Surgery Date: 2013-12 Impact factor: 3.982